Fig. 4
From: RDGN-based predictive model for the prognosis of breast cancer
The relationship between EYA2 and breast cancer. a EYA2 is lower in breast cancer compared with normal tissues; b EYA2 level is lower in Luminal A and B subtypes than Basal-like and Her-2 enriched subtypes; Survival curves of EYA2 high or low breast cancer patients: overall survival (OS) (c), relapse-free survival (RFS) (d), distant metastasis-free survival (DMFS) (e), and post-progression survival (PPS) (f)